[ad_1]
PITTSBURGH, July 12, 2019 – The new live donor liver transplant offers many benefits over a deceased donor transplant, including better patient survival at three years and lower costs. , according to a new research from the UPMC Transplant Institute Thomas E. Starzl and the University of Pittsburgh School of Medicine.
The results, published online today in the Annals of surgery, highlighting living donation as a viable, if not preferable, option for the more than 14,000 people currently on the waiting list, as well as for many others who never qualify for the list under the rules current allocation.
According to the organ research and transplant network, approximately 8,000 liver transplants are performed each year, and live donor liver transplants account for less than 5% of this total. In addition, about 25% of people on the waiting list die every year while waiting for a transplant. In addition, those who end up with a transplant often have a long time on the waiting list, which affects their health at the time of the transplant.
"The consequences for patients on the waiting list can make the difference between life and death because the longer they wait, the sicker they become," said Abhinav Humar, MD, head of transplantation services at UPMC, clinical director of the Thomas E. Starzl Transplantation Institute and lead author of the study. "Living donor liver transplants, combined with deceased donor liver transplants, represent an opportunity to significantly reduce the risk of mortality on waiting list and allow us to graft a person faster."
Retrospective review of 245 adult live donor liver transplants and 592 deceased donor liver transplants performed in the past 10 years at UPMC – which has the largest living donor liver transplant program in the country – compared rates survival and other outcomes such as recovery time, complications, costs and resource utilization. Patients were followed for at least two years after the transplant.
Among these comparisons, the survival results of patients at three years were higher in living donor liver transplant recipients – 86% versus 80%. Living donor liver transplant recipients overall had a survival advantage of about 5% compared to deceased recipients. Patients who received the liver from a living donor had an 11-day hospitalization versus 13 days for those who had received the liver from a deceased donor, were less likely to undergo an intraoperative blood transfusion (53% vs. 78%) and less post-transplant dialysis (1.6% versus 7.4%). Hospital costs related to transplantation were also 29.5% lower for living donors. For the living liver donor, no mortality was observed and the overall complication rate was 20%.
"The liver transplant of a living donor should be considered the first and the best option for most patients with liver disease," said Humar. "This is not just an option for people on the waiting list, but could possibly offset the fact that anyone who could benefit from a transplant is not eligible to receive a transplant from a deceased donor on the basis of the current allocation rules in effect. "
In view of its advantages, in recent years UPMC has expanded its living donor liver transplant program. In 2018, live donor transplants accounted for about 54% of the total number of liver transplants in the program, compared to the national average of about 4%. The UPMC transplant rate has also increased from 45 people on the program's waiting list in 2015 to around 88 in 2018. The program has led the country in living donor liver transplants during last two years and is the only center in the United States to have performed more live transplants than deceased donors.
"It's unclear why the number of live donor liver transplants is so low in the United States," said Amit Tevar, MD, badociate professor of surgery at Pitt's Department of Surgery and director of the kidney transplant program and of pancreas at the UPMC. "Fewer than 15 US programs have performed more than 10 live donor liver transplants in 2018, which is surprising given the number of national badyzes conducted in this country."
###
Other authors of the study include Swaytha Ganesh, M.D., Dana Jorgensen, Ph.D., M.P.H., Armando Ganoza, M.D., Michele Molinari, M.D., and Christopher Hughes, M.D., all of Pitt.
To read this version online or share it, visit http: // www.
About UPMC
A 20-billion-dollar health care provider and insurer, the UPMC, based in Pittsburgh, invents new models of responsible, cost-effective and patient-centered care. The largest non-governmental employer in Pennsylvania, UPMC has 87,000 employees, 40 hospitals, 700 medical offices and outpatient clinics, as well as an insurance services division of 3.5 Millions of members, the largest medical insurer in western Pennsylvania. In the last fiscal year, UPMC provided $ 1.2 billion to its communities, including more care for the most vulnerable citizens in the region than any other health care facility, and paid $ 587 million. dollars in federal, state and local taxes. Working closely with the University of Pittsburgh School of Health Sciences, UPMC shares clinical, managerial and technological expertise around the world through its Innovation and Commercialization Division, UPMC Enterprises , and UPMC International. US News & World Report regularly ranks the UPMC Presbyterian Shadyside in its annual honor board of the best hospitals in America. For more information, visit UPMC.com.
About the School of Medicine at the University of Pittsburgh
As one of the country's leading university-based biomedical research centers, the University of Pittsburgh's Faculty of Medicine integrates leading-edge technologies into the basic sciences across a wide range of disciplines in order to mobilize potential of new knowledge and to improve the human condition. Under the leadership of the Faculty of Medicine and its affiliates, Pitt ranks among the top 10 recipients of National Institutes of Health funding since 1998. In recent rankings published by the National Science Foundation, Pitt ranked fifth among all American universities supporting research and development in science and engineering.
Likewise, the Faculty of Medicine is also committed to improving the quality and strength of its medical and higher education programs, for which it is recognized as an innovative leader, and to training highly qualified, compbadionate clinicians and clinicians. creative scientists well equipped to participate world-clbad research. The School of Medicine is the academic partner of the UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and position health care as a driving force for Economy of the region. For more information on the Faculty of Medicine, see http: // www.
http: // www.
Contact: Lawerence Synett
Office: 412-647-9816
Mobile: 412-302-4127
Email: [email protected]
Contact: Wendy Zellner
Office: 412-586-9777
Mobile: 412-973-7266
E-mail: [email protected]
Source link
